FENORTHO is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sterling Knight Pharmaceuticals Llc. The primary component is Fenoprofen Calcium.
| Product ID | 69336-113_bedf1661-b811-3d85-e053-2995a90acd59 |
| NDC | 69336-113 |
| Product Type | Human Prescription Drug |
| Proprietary Name | FENORTHO |
| Generic Name | Fenortho |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-03-21 |
| Marketing Category | NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC |
| Application Number | NDA017604 |
| Labeler Name | Sterling Knight Pharmaceuticals LLC |
| Substance Name | FENOPROFEN CALCIUM |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2017-03-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA authorized generic |
| Application Number | NDA017604 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-03-21 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA authorized generic |
| Application Number | NDA017604 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-03-21 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| FENOPROFEN CALCIUM | 200 mg/1 |
| SPL SET ID: | 8ca03d72-6c10-4c62-94c5-bf1edd164bf4 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |